Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) announced its earnings results on Thursday. Ligand Pharmaceuticals Trading Down 2.3%Shares of NASDAQ LGND traded down $6.99 during trading on Friday, hitting $293.15. Ligand Pharmaceuticals has a 12-month low of $137.14 and a 12-month high of $326.63. Also, insider Andrew Reardon sold 5,000 shares of Ligand Pharmaceuticals stock in a transaction that occurred on Monday, August 3rd. Featured StoriesReceive News & Ratings for Ligand Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ligand Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.